American Society of Clinical Oncology

SHERPA: White

People

  1. Yahalom
    Yahalom
  2. Wolden
    Wolden
  3. Yamada
    Yamada
  4. Bosl
    Bosl
  5. Cheung
    Cheung
  6. Correa
    Correa
  7. De Angelis
    De Angelis
  8. Gutin
    Gutin
  9. Horwitz
    Horwitz
  10. Hudis
    Hudis

Groups

  1. Radiation Oncology, Department of (10)
  2. Survivorship Research (8)
  3. Population Sciences Research Program (4)
  4. Center for Hematologic Malignancies (3)
  5. Department of Medicine (3)
  6. Surgery (3)
  7. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (2)
  8. GSK Faculty (2)
  9. Pediatric Leukemia (2)
  10. Solid Tumor Oncology Division (2)
Search Within
  1. "Radiation Oncology, Department of"
  2. "Journal of Clinical Oncology"
  3. "2004"
Formats
  1. Meeting Abstract (10)
Groups
  1. Radiation Oncology, Department of (10)
  2. Survivorship Research (8)
  3. Population Sciences Research Program (4)
  4. Center for Hematologic Malignancies (3)
  5. Department of Medicine (3)
  6. Surgery (3)

More Groups

People
  1. Joachim Yahalom (3)
  2. Michael Zelefsky (2)
  3. Suzanne Wolden (2)
  4. Yoshiya Yamada (2)
  5. Andrew Vickers (1)
  6. Andrew Zelenetz (1)

More People

Years
  1. 2004 (10)
Publications
  1. Journal of Clinical Oncology (10)

Results (10)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Double-blind, randomized trial of granulocyte-colony stimulating factor (GCSF) versus (v.) placebo during postoperative radiation (RT) for advanced resectable squamous cell head and neck cancer (SCCHN): Impact on mucositis
    Meeting Abstract

    Su, Y. B.; Vickers, A.; Zelefsky, M. J.; Kraus, D. H.; Shaha, A. R.; Shah, J. P.; Lake, S.; Harrison, L. B.; Bosl, G. J.; Pfister, D. G.
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save
  • Feasibility of breast conserving treatment for breast cancer in women with germline BRCA mutations: A clinic-based series
    Meeting Abstract

    Robson, M.; Holcombe, T.; McCormick, B.; Borgen, P.; Gulati, T.; Jhanwar, S.; Kauff, N.; Hudis, C.; Norton, L.; Offit, K.
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save
  • Intensity modulated radiotherapy in high grade gliomas: Clinical and dosimetric results
    Meeting Abstract

    Narayana, A.; Yamada, J.; Hunt, M.; Shah, P.; Gutin, P.; Leibel, S. A.
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save
  • Practice type & race influence enrollment onto clinical oncology trials: A Patterns of Care Study analysis
    Meeting Abstract

    Movsas, B.; Moughan, J.; Owen, J.; Coia, L. R.; Zelefsky, M. J.; Hanks, G. E.; Wilson, J. F.
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save
  • Long term complications from treatment in survivors of high risk neuroblastoma
    Meeting Abstract

    Laverdiere, C.; Cheung, N. K. V.; Kushner, B. H.; Kramer, K.; Modak, S.; La Quaglia, M. P.; Wolden, S.; Ness, K. K.; Gurney, J. G.; Sklar, C. A.
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save
  • Feasibility and preliminary efficacy of R-CHOP-14 in patients with diffuse large B-cell lymphoma (DLBCL)
    Meeting Abstract

    Halaas, J. L.; Moskowitz, C. H.; Noy, A.; Portlock, C.; Horwitz, S.; Straus, D.; O'connor, O.; Yahalom, J.; Zelenetz, A. D.
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save
  • Combined immunochemotherapy with reduced dose whole brain radiotherapy (WBRT) for newly diagnosed patients with primary CNS lymphoma (PCNSL)
    Meeting Abstract

    El Kamar, F. G.; Deangelis, L. M.; Yahalom, J.; Correa, D. D.; Grant, B. W.; Larocca, R. V.; Raizer, J. J.; Schiff, D.; Abrey, L. E.
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save
  • Cardiac toxicity in a phase II study of doxorubicin (DOX) and bevacizumab (BEV) for patients (pts) with metastatic soft-tissue sarcomas
    Meeting Abstract

    D'adamo, D. R.; Anderson, S.; Albritton, K.; Yamada, J.; Riedel, E.; Scheu, K.; Schwartz, G. K.; Chen, H.; Maki, R. G.
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save
  • Assessment of response to induction therapy and its influence on 5-year failure-free survival (FFS) in Group III rhabdomyosarcoma (RMS): Intergroup Rhabdomyosarcoma Study ORSHV experience
    Meeting Abstract

    Breitfeld, P. P.; Anderson, J.; Kao, S.; Rodeberg, D.; Qualman, S.; Wolden, S.; Meyer, W.
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save
  • Excellent long-term experience with primary bone lymphoma: Analysis of prognostic factors
    Meeting Abstract

    Beal, K. P.; Allen, L. F. H.; Yahalom, J.
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save